View : 964 Download: 0

Cementless revision for infected total hip replacements

Title
Cementless revision for infected total hip replacements
Authors
Kim Y.-H.Kim J.-S.Park J.-W.Joo J.-H.
Ewha Authors
김영후김준식박장원
SCOPUS Author ID
김영후scopus; 김준식scopusscopus; 박장원scopus
Issue Date
2011
Journal Title
Journal of Bone and Joint Surgery - Series B
ISSN
0301-620XJCR Link
Citation
Journal of Bone and Joint Surgery - Series B vol. 93 B, no. 1, pp. 19 - 26
Indexed
SCOPUS WOS scopus
Document Type
Article
Abstract
Our aim was to determine the success rate of repeated debridement and two-stage cementless revision arthroplasty according to the type of infected total hip replacement (THR). We enrolled 294 patients (294 hips) with an infected THR in the study. There were 222 men and 72 women with a mean age of 55.1 years (24.0 to 78.0). The rate of control of infection after the initial treatment and after repeated debridement and two-stage revisions was determined. The clinical (Harris hip score) and radiological results were evaluated. The mean follow-up was 10.4 years (5.0 to 14.0). The eventual rate of control of infection was 100.0% for early superficial post-operative infection, 98.4% for early deep post-operative infection, 98.5% for late chronic infection and 91.0% for acute haematogenous infection. Overall, 288 patients (98%) maintained a functioning THR at the latest follow-up. All the allografts appeared to be united and there were no failures. These techniques effectively controlled infection and maintained a functional THR with firm fixation in most patients. Repeated debridement and two-stage or repeated two-stage revisions further improved the rate of control of infection after the initial treatment and increased the likelihood of maintaining a functional THR. ©2011 British Editorial Society of Bone and Joint Surgery.
DOI
10.1302/0301-620X.93B1.25120
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE